扭立生ＳＡ注射液

Country: Taiwan

Language: Chinese

Source: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

Active ingredient:

HISTIDINE;;SERINE;;PROLINE;;ISOLEUCINE;;SORBITOL;;GLYCINE (EQ TO AMINOACETIC ACID)(EQ TO GLYCOCOLL);;METHIONINE;;VALINE;;LYSINE;;CYSTINE;;ASPARTIC ACID;;TRYPTOPHAN;;ALANINE;;ARGININE;;THREONINE;;PHENYLALANINE;;GLUTAMIC ACID;;TYROSINE;;LEUCINE

Available from:

中國振業有限公司 台北巿忠孝東路四段２１９號１１樓 (03082906)

Pharmaceutical form:

注射劑

Composition:

ALANINE (4020100200) 5.00%; ARGININE (4020100300) 12.85%; ASPARTIC ACID (4020100400) 5.75%; CYSTINE (4020100600) 2.25%; GLUTAMIC ACID (4020100700) 13.65%; HISTIDINE (4020100900) 1.50%; ISOLEUCINE (4020101000) 3.15%; LEUCINE (4020101200) 5.50%; LYSINE (4020101300) 4.50%; METHIONINE (4020101500) 6.05%; PHENYLALANINE (4020101700) 2.05%; PROLINE (4020101800) 6.90%; SERINE (4020101900) 9.90%; THREONINE (4020102000) 6.65%; TRYPTOPHAN (4020102100) 2.25%; TYROSINE (4020102200) 0.85%; VALINE (4020102300) 6.20%; GLYCINE (EQ TO AMINOACETIC ACID)(EQ TO GLYCOCOLL) (4020102400) 5.00%; SORBITOL (9600029600) 50GM

Units in package:

瓶裝

Class:

製　劑

Prescription type:

限由醫師使用

Manufactured by:

LES LABORATOIRES BRUNEAU ET CIE PARIS FR

Therapeutic indications:

營養失調症、貧血、外科手術前後、初期肝硬變症、傳染病回復期等

Product summary:

註銷日期: 1992/03/16; 註銷理由: 公司歇業; 有效日期: 1984/06/15; 英文品名: NUTRILYSAT S.A.

Authorization status:

已註銷

Authorization date:

1969-06-16